Home
ParaPRO

ParaPRO Market Share Analysis for May 2026

For more than 35 years, healthcare providers have selectively used permethrin to eradicate the scabies mite—the same molecule that has resulted in widespread resistance in head lice.

Industry: N/A

Domainparapro.com

Year Founded2002

Employees51 - 200

Annual Revenue$5M - $10M

ParaPRO

ParaPRO (including company regionals)

parapro.com

See more website traffic and engagement information

ParaPRO Revenue up to May 2026 is 5M - 10M

revenue generated by ParaPRO top domains

ParaPRO top domains revenue over 3 years

Revenue for ParaPRO top domains

parapro.com5M - 10M

See more with Sales Intelligence

Total visits to ParaPRO's top domains

Understand ParaPRO market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

parapro.com3.2K

See more with Sales Intelligence

Avg. visit duration in ParaPRO's top domains

Analyze ParaPRO engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

parapro.com00:00:11

See more with Sales Intelligence

Avg. pageviews on ParaPRO's top domains

See how ParaPRO keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

parapro.com2.40

See more with Sales Intelligence

ParaPRO top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by ParaPRO

These are the website technologies, by industry, used by ParaPRO top domains

Advertising (4)

DoubleClick

Widget (4)

Twemoji

Audio Video Media (3)

HTTP Live Streaming (HLS)

Email Services (3)

Microsoft Exchange Online

More Technologies

8

See all

News & Signals from ParaPRO

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsParaPRO, LLC. sells assets to Cipher Pharmaceuticals Inc. in the amount of $89.5M.MISSISSAUGA - Cipher Pharmaceuticals acquires global product rights for Natroba (Spinosad) and the U.S. commercial sales team from ParaPRO, in a deal valued at USD 89.5 million.

NewsParaPRO, LLC. launches Thought Leader AI.ParaPRO, a specialty pharmaceutical company focused on innovative treatments for human ectoparasites, today announced that it will unveil Thought Leader AI – a pioneering medical education platform that enables healthcare practitioners to engage "live" with leading clinical experts on topics of public health – at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Anaheim, CA, October 7-11, 2022.

NewsParaPRO, LLC. launched Natroba Topical Suspension on Jan 9th '19.ParaPRO, a specialty pharmaceutical company focused on innovative anti-parasitic treatments, today announced the availability of Natroba™ (spinosad) Topical Suspension, 0.9%, the first product (new drug application) for scabies to be approved by the U.S. Food and Drug Administration (FDA) in more than 30 years.